These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1419985)

  • 1. Decompensation in proteinase-inhibitor system and application of proteinase inhibitors in pemphigus and pemphigoid.
    Grando SA
    J Dermatol Sci; 1992 Sep; 4(2):95-7. PubMed ID: 1419985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid.
    Grando SA; Glukhenky BT; Drannik GN; Epshtein EV; Kostromin AP; Korostash TA
    Arch Dermatol; 1989 Jul; 125(7):925-30. PubMed ID: 2662908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.
    Bhol KC; Rojas AI; Khan IU; Ahmed AR
    Cytokine; 2000 Jul; 12(7):1076-83. PubMed ID: 10880254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoreactive cytotoxic T lymphocytes in pemphigus and pemphigoid.
    Grando SA; Glukhenky BT; Drannik GN; Kostromin AP; Boiko YYa ; Senyuk OF
    Autoimmunity; 1989; 3(4):247-60. PubMed ID: 2491630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid.
    Kowalski EH; Kneibner D; Kridin K; Amber KT
    Autoimmun Rev; 2019 May; 18(5):526-534. PubMed ID: 30844553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid.
    Kakinuma T; Wakugawa M; Nakamura K; Hino H; Matsushima K; Tamaki K
    Br J Dermatol; 2003 Feb; 148(2):203-10. PubMed ID: 12588369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of collagenase and elastase activities in the blister fluids from bullous skin diseases. Comparison between dermatitis herpetiformis and bullous pemphigoid.
    Oikarinen AI; Zone JJ; Ahmed AR; Kiistala U; Uitto J
    J Invest Dermatol; 1983 Sep; 81(3):261-6. PubMed ID: 6309988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune complexes in pemphigus and bullous pemphigoid.
    Ahmed AR; Moy RL; Chia D; Barnett EV
    Dermatologica; 1983; 166(4):175-80. PubMed ID: 6343146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine pattern in blister fluid and sera of patients with pemphigus.
    Baroni A; Perfetto B; Ruocco E; Greco R; Criscuolo D; Ruocco V
    Dermatology; 2002; 205(2):116-21. PubMed ID: 12218224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris.
    Czech W; Schaller J; Schöpf E; Kapp A
    J Am Acad Dermatol; 1993 Aug; 29(2 Pt 1):210-5. PubMed ID: 8393016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic proteases in blister fluid of pemphigus and pemphigoid patients.
    Grando SA; Glukhenky BT; Drannik GN; Kostromin AP; Chernyavsky AI
    Int J Tissue React; 1989; 11(4):195-201. PubMed ID: 2699467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between IL36α and IL17 and Activity of the Disease in Selected Autoimmune Blistering Diseases.
    Żebrowska A; Woźniacka A; Juczyńska K; Ociepa K; Waszczykowska E; Szymczak I; Pawliczak R
    Mediators Inflamm; 2017; 2017():8980534. PubMed ID: 28611508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyshidrosiform Pemphigus vulgaris: Report of an unusual case.
    Gharami RC; Kumar P; Mondal A; Ghosh K
    Dermatol Online J; 2010 Jul; 16(7):10. PubMed ID: 20673538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased tryptase and myeloperoxidase levels in blister fluids of patients with bullous pemphigoid: correlations with cytokines, adhesion molecules and anti-basement membrane zone antibodies.
    D'Auria L; Pietravalle M; Cordiali-Fei P; Ameglio F
    Exp Dermatol; 2000 Apr; 9(2):131-7. PubMed ID: 10772387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study of toll-like receptors 2, 4, and 9 expressions in pemphigus and bullous pemphigoid lesions.
    Sun XK; Chen JF; Shen H
    Arch Dermatol Res; 2016 Aug; 308(6):429-36. PubMed ID: 27221282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients.
    Kasperkiewicz M; Shimanovich I; Ludwig RJ; Rose C; Zillikens D; Schmidt E
    J Am Acad Dermatol; 2011 Sep; 65(3):552-558. PubMed ID: 21641080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of kallikrein-kinin system components in the pathogenesis of bullous skin lesions in pemphigus and pemphigoid].
    Grando SA; Glukhen'kiĭ BT; Kostromin AP; Boĭko IuIa; Kutsenko NS; Korostash TA
    Vopr Med Khim; 1990; 36(1):23-7. PubMed ID: 2188426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent in situ expression of IL-31 and IL-31RA between bullous pemphigoid and pemphigus vulgaris.
    Ergun EZ; Aoki R; Horváth ON; Hartmann D; Satoh TK; Calabrese L; Aksu AEK; Gürel MS; Manav V; Flaig MJ; Sárdy M; Ruzicka T; French LE; Bağcı IS
    Exp Dermatol; 2023 Sep; 32(9):1412-1419. PubMed ID: 37260420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of eccrine glands and hair follicles in direct immunofluorescent analysis of pemphigus vulgaris and bullous pemphigoid.
    Zhou C; Yu Y; Elston DM
    J Cutan Pathol; 2016 Apr; 43(4):334-8. PubMed ID: 26749398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris.
    Asashima N; Fujimoto M; Watanabe R; Nakashima H; Yazawa N; Okochi H; Tamaki K
    Br J Dermatol; 2006 Aug; 155(2):330-6. PubMed ID: 16882171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.